Skip to main content
SIU School of Medicine Logo

Domain Menu

  • Patient Care
  • School of Medicine

Main Menu Edu Secondary

  • faculty
  • intranet
  • library
  • news & events
  • donate
  • careers
I am a...
  • Patient
  • Donor or Friend
  • Prospective Employee
  • Student/Prospective Student
  • Resident or Fellow
  • Alumni

Main Menu Edu

Main Menu Close
Main Menu
  • Degree Programs
  • Research
  • Academic & Clinical Departments
  • Centers & Institutes
  • Community Programs
    • Equity, Diversity and Inclusion
    • External Relations
    • Family and Community Medicine
    • Office of Community Care
    • Office of Correctional Medicine
    • Population Science and Policy
    • Rural Health and Social Service Development
  • About Us
    • Administrative offices
    • Careers
    • Why SIU School of Medicine
      • Strategic plan
      • A Model for Medical Education
      • Facts and figures
      • Our campuses
    • Economic Impact Report (pdf)
    • History
      • Notable alumni
      • Points of pride
      • Timeline
    • Leadership
      • SIU Medicine Board of Directors
      • SIU School of Medicine Leadership
    • News and Events
Search Site close Close

Breadcrumb

  1. Home
  2. Trials and Research Search
clinical trials

Clinical trials and research studies

At SIU Medicine, our researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.
Enroll today
search
Reset

Filter Results

Activity Status

  • Active, recruiting (2)

Treatment

  • (-) Diseases of the Lungs (2)
  • Abdominal Aortic Aneurysm (1)
  • Alzheimer's Disease (3)
  • Breast Cancer (3)
  • Cervical Cancer (1)
  • Depression (2)
  • Endometrial Cancer (1)
  • Endometriosis (1)
  • Epilepsy (5)
  • Erectile Dysfunction (ED) (1)
  • Heart Disease (1)
  • High Blood Pressure (Hypertension) (8)
  • Leukemia (1)
  • Male Infertility (1)
  • Melanoma (1)
  • Myeloma (1)
  • Neuro-Critical Care (1)
  • Ovarian Cancer (3)
  • Parkinson's Disease (1)
  • Psoriasis (1)
  • Schizophrenia (2)
  • Stroke (2)
  • Transcranial Magnetic Stimulation (TMS) (1)

Department

  • Infectious Diseases (1)
  • Internal Medicine (2)
  • Pulmonary and Critical Care (1)
Reset

Filter Results

Activity Status

  • Active, recruiting (2)

Treatment

  • (-) Diseases of the Lungs (2)
  • Abdominal Aortic Aneurysm (1)
  • Alzheimer's Disease (3)
  • Breast Cancer (3)
  • Cervical Cancer (1)
  • Depression (2)
  • Endometrial Cancer (1)
  • Endometriosis (1)
  • Epilepsy (5)
  • Erectile Dysfunction (ED) (1)
  • Heart Disease (1)
  • High Blood Pressure (Hypertension) (8)
  • Leukemia (1)
  • Male Infertility (1)
  • Melanoma (1)
  • Myeloma (1)
  • Neuro-Critical Care (1)
  • Ovarian Cancer (3)
  • Parkinson's Disease (1)
  • Psoriasis (1)
  • Schizophrenia (2)
  • Stroke (2)
  • Transcranial Magnetic Stimulation (TMS) (1)

Department

  • Infectious Diseases (1)
  • Internal Medicine (2)
  • Pulmonary and Critical Care (1)
Showing: 2 Results
search
Trial
Infectious Diseases

A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Multicenter, Prospective Study to Assess the Efficacy, Safety, and Pharmacokinetics of Orally Administered Epetraborole in Patients with Treatment-refractory Mycobacterium aviu

Active recruiting

The purpose of this clinical trial is to assess the effectiveness of Epetraborole, taken once daily, in patient populations with treatment-refractory MAC lung disease.

Eligible patients include those who currently have a positive MAC sputum culture despite receiving a combination regimen of at least 2 antimycobacterial agents administered for at least 6 months.

Contact: Katherine Martz phone217-545-4342 emailkmartz35@siumed.edu
Trial
Pulmonary and Critical Care

ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Myco

Active recruiting

The purpose of this clinical trial is to assess the effectiveness of ARIKAYCE, inhaled once daily, in patient populations with mild and untreated MAC lung infection. 

Eligible patients include those who currently have a positive MAC sputum culture and have not received treatment for their infection.

Contact: Katherine Martz phone217-545-4342 emailkmartz35@siumed.edu
Go back to search filters

This browser is no longer supported and some key features will not work. We strongly recommend using Edge, Chrome 70+, Safari 5.x+ and Firefox 5.x+.

SIU School of Medicine Logo
© 2025 SIU Board of Trustees all rights reserved

Legal

  • Equal Opportunity Employer
  • Nondiscrimination Statement
  • Privacy Policy
  • FOIA
  • ADA

About Us

  • About Us
  • Contact
  • SIU Intranet
  • SIU Medicine
  • Southern Illinois University Carbondale
  • Southern Illinois University Edwardsville
  • Southern Illinois University System

Social

  • Facebook
  • Twitter
  • Youtube
  • Instagram